1-6 of 6
Shirali Agarwal
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety of Recombinant Erwinia Asparaginase (JZP458) in Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL): Complete Follow-up of the Children's Oncology Group (COG) AALL1931 Study

Luke Maese, Mignon L. Loh, Mi Rim Choi, Tong Lin, Etsuko Aoki, Shirali Agarwal, Vijayalakshmi Chandrasekaran, Yali Liang, Suzette Girgis, Cuiping Chen, Robert Iannone, Lewis B. Silverman, Elizabeth A. Raetz, Rachel E. Rau
Journal: Blood
Blood (2023) 142 (Supplement 1): 1498.
https://doi.org/10.1182/blood-2023-172577
Published: 2023
Journal Articles

Immunogenicity of Recombinant Erwinia asparaginase (JZP458) for Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)

Luke Maese, Mignon L. Loh, Mi Rim Choi, Yali Liang, Etsuko Aoki, Shane Roller, Tong Lin, Shirali Agarwal, Vijayalakshmi Chandrasekaran, Robert Iannone, Lewis B. Silverman, Elizabeth A. Raetz, Rachel E. Rau
Journal: Blood
Blood (2023) 142 (Supplement 1): 5908.
https://doi.org/10.1182/blood-2023-179533
Published: 2023
Journal Articles

Recombinant Erwinia asparaginase (JZP458) in acute lymphoblastic leukemia: results from the phase 2/3 AALL1931 study

Clinical Trials & Observations
Luke Maese, Mignon L. Loh, Mi Rim Choi, Tong Lin, Etsuko Aoki, Michelle Zanette, Shirali Agarwal, Robert Iannone, Jeffrey A. Silverman, Lewis B. Silverman, Elizabeth A. Raetz, Rachel E. Rau
Journal: Blood
Blood (2023) 141 (7): 704–712.
https://doi.org/10.1182/blood.2022016923
Published: 2023
Includes: Supplemental data
Journal Articles

Efficacy, Safety, and Population Pharmacokinetic Modeling of Intravenous Recombinant Erwinia Asparaginase (JZP458) in Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma: Results from Study AALL1931

Luke Maese, Mignon L. Loh, Mi Rim Choi, Tong Lin, Etsuko Aoki, Shirali Agarwal, Xiaotian Wu, Robert Iannone, Jeffrey A. Silverman, Lewis B. Silverman, Elizabeth A. Raetz, Rachel E. Rau
Journal: Blood
Blood (2022) 140 (Supplement 1): 8969–8970.
https://doi.org/10.1182/blood-2022-160192
Published: 2022
Journal Articles

Initial Results from a Phase 2/3 Study of Recombinant Erwinia Asparaginase (JZP458) in Patients with Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL) Who Are Allergic/Hypersensitive to E. coli-Derived Asparaginases

Luke Maese, Mignon L. Loh, Tong Lin, Etsuko Aoki, Michelle Zanette, Shirali Agarwal, Jeffrey A. Silverman, Mi Rim Choi, Lewis B. Silverman, Elizabeth A. Raetz, Rachel E. Rau
Journal: Blood
Blood (2021) 138 (Supplement 1): 2307.
https://doi.org/10.1182/blood-2021-147023
Published: 2021
Journal Articles

Predictors of 90-Day Mortality after Admission to Intensive Care Unit (ICU) in Patients with Acute Myeloid Leukemia (AML): Application of a Novel, Recently Validated AML-Specific Risk Model

Ylinne Lynch, MD, Shirali Agarwal, MD, Matthew Modes, MD MPP, Matthew Triplette, MD MPH, Masumi Ueda, MD, Barry E. Storer, PhD, Mary-Elizabeth M. Percival, MD MS, Pamela S. Becker, MD, Brenda M. Sandmaier, MD, Frederick R. Appelbaum, MD, Elihu H. Estey, MD, Mohamed L. Sorror, MD MSc
Journal: Blood
Blood (2018) 132 (Supplement 1): 3986.
https://doi.org/10.1182/blood-2018-99-115419
Published: 2018